In the complicated landscape of health care, one thing is abundantly clear — the current drug pricing system is broken. It’s a sentiment echoed by patients, health care providers, insurers, pharmacy benefit managers (PBMs), manufacturers, and researchers alike. The system, as it stands, fails to serve anyone’s interests adequately, least of all the patients who bear the brunt of its shortcomings at the pharmacy counter.
How lawmakers can protect copay assistance
March 18, 2024